ArticleThe Journal of clinical endocrinology and metabolism2022

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects.

Venessa Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.